Daniele Carmagnini

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

M. Ulivelli, G. Marfia, M. Sormani, 2021, EBioMedicine.

Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study

M. Devoto, F. Cucca, M. Masala, 2022, Frontiers in Immunology.

Cannabinoids and dystonia: an issue yet to be defined

G. Defazio, M. Mascia, Daniele Carmagnini, 2019, Neurological Sciences.

The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis.

L. Saba, G. Fenu, J. Frau, 2019, Multiple sclerosis and related disorders.

Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination

M. Piras, M. Steri, V. Orrù, 2024, Frontiers in Immunology.